Back to Rankings

SLGL

Sol-GelD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SLGL vs peer average
44/100
SLGL vs. peer average (D vs. D)
Grade spread
A 2 · C 3 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ABOS is the first available peer comparator.

Small-cap clinical biotech comparator for single-program readout risk, capital markets dependence, and event-driven valuation swings.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerABOSAcumen
SLGL
Sol-Gel
ABOS
Acumen
Grade
D
A
Momentum
68
72
Value
48
41
Sentiment
32
79
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs ABOS

SLGL / ABOS
Grade Position
Below peers
SLGL vs. peer average (D vs. D)
44/100
Momentum
68
ABOS
Value
48
SLGL
Sentiment
32
ABOS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SLGL
1
ABOS
ABOS
A
100/100
-3
2
CGTX
CGTX
C
60/100
-1
3
KPTI
KPTI
C
60/100
-1
4
GALT
Galectin Therapeutics Inc Common
A
100/100
-3
5
TLSI
TriSalus Life Sciences Inc Common
F
20/100
+1
ABOS is the first peer returned for this comparison set.